Cargando…

Real-world use of procalcitonin and other biomarkers among sepsis hospitalizations in the United States: A retrospective, observational study

BACKGROUND: Sepsis management guidelines endorse use of biomarkers to support clinical assessment and treatment decisions in septic patients. The impact of biomarkers on improving patient outcomes remains uncertain. METHODS: Retrospective observational study of adult sepsis discharges between Januar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gluck, Eric, Nguyen, H. Bryant, Yalamanchili, Kishore, McCusker, Margaret, Madala, Jaya, Corvino, Frank A., Zhu, Xuelian, Balk, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192638/ https://www.ncbi.nlm.nih.gov/pubmed/30332466 http://dx.doi.org/10.1371/journal.pone.0205924

Ejemplares similares

Procalcitonin and Other Biomarkers of Sepsis in Newborns in the Intensive Care Unit
por: Bartolovic, Daniela, et al.
Publicado: (2011)

Challenges in Procalcitonin Implementation in the Real-World
por: Nguyen, Cynthia T, et al.
Publicado: (2018)

Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients
por: Schuetz, Philipp, et al.
Publicado: (2013)

Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit
por: BalcI, Canan, et al.
Publicado: (2003)

Serum procalcitonin in sepsis
por: Wiwanitkit, Viroj
Publicado: (2011)

Procalcitonin in paediatric sepsis
por: Hatherill, M, et al.
Publicado: (1998)

Real-world treatment patterns for patients receiving second-line and third-line treatment for advanced non-small cell lung cancer: A systematic review of recently published studies
por: Davies, Jessica, et al.
Publicado: (2017)

Procalcitonin as an adjunctive biomarker in sepsis
por: Sinha, Mahua, et al.
Publicado: (2011)

Procalcitonin in autoimmune disease with sepsis
por: Leonhardt, U, et al.
Publicado: (2001)

Significance of serum procalcitonin in sepsis
por: Sudhir, Uchil, et al.
Publicado: (2011)

Procalcitonin-guided antibiotics in severe sepsis
por: Simon, Peter, et al.
Publicado: (2008)

Procalcitonin – Assisted Antibiotic Strategy in Sepsis
por: Trásy, Domonkos, et al.
Publicado: (2017)

Procalcitonin as a prognostic marker for sepsis: a prospective observational study
por: Jain, Saransh, et al.
Publicado: (2014)

Diagnostic value of procalcitonin and IL-6 for sepsis of older patients and other patients in the emergency department
por: Woo, SH
Publicado: (2015)

Procalcitonin as a prognostic marker for sepsis based on SEPSIS‐3
por: Jekarl, Dong Wook, et al.
Publicado: (2019)

Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study
por: Schuetz, Philipp, et al.
Publicado: (2017)

Anaplastic lymphoma kinase rearrangement prevalence in patients with advanced non-small cell lung cancer in the United States: retrospective real world data
por: Allen, Timothy Craig, et al.
Publicado: (2021)

Procalcitonin Predicts Real-Time PCR Results in Blood Samples from Patients with Suspected Sepsis
por: Mencacci, Antonella, et al.
Publicado: (2012)

What procalcitonin brings to management of sepsis in the ICU
por: Wolff, Michel, et al.
Publicado: (2010)

Evaluation of procalcitonin in patients with sepsis in Albanian adults
por: Puca, E, et al.
Publicado: (2012)

Predictive values for procalcitonin in the diagnosis of neonatal sepsis
por: Mohsen, Abdel Hakeem Abdel, et al.
Publicado: (2015)

Plasma procalcitonin concentrations are increased in dogs with sepsis
por: Goggs, Robert, et al.
Publicado: (2018)

Impact of Procalcitonin-Guided Antibiotic Management on Antibiotic Exposure and Outcomes: Real-world Evidence
por: Broyles, Michael R
Publicado: (2017)

Serum Procalcitonin and Procalcitonin Clearance as a Prognostic Biomarker in Patients with Severe Sepsis and Septic Shock
por: Huang, Min-Yi, et al.
Publicado: (2016)

Mortality Rate of Sepsis Patients in the Intensive Care Unit: The Prognostic Role of Ejection Fraction and Procalcitonin
por: Hejazi, Mohammad Esmaeil, et al.
Publicado: (2021)

Procalcitonin Use for Predicting Mortality and Morbidity of Patients Diagnosed With Sepsis Within the Intensive Care Unit
por: Chew, Christopher R, et al.
Publicado: (2023)

The quest for quarks
por: McCusker, Brian
Publicado: (1983)

Cellular self-organization: generating order from the abyss
por: McCusker, Derek
Publicado: (2020)

The United Nations Convention on the Rights of Persons with Disabilities and Social Work: Evidence for Impact?
por: McCusker, Pearse, et al.
Publicado: (2023)

Evaluation of procalcitonin for diagnosis of neonatal sepsis of vertical transmission
por: López Sastre, José B, et al.
Publicado: (2007)

Procalcitonin as a marker of bacterial sepsis in immunocompromised patients
por: Gatserelia, Lana, et al.
Publicado: (2012)

Procalcitonin: A Reliable Marker for the Diagnosis of Neonatal Sepsis
por: Adib, Minoo, et al.
Publicado: (2012)

Procalcitonin-guided therapy in severe sepsis and septic shock
por: Gu, Wan-Jie, et al.
Publicado: (2014)

Monitoring treatment response in abdominal sepsis with procalcitonin - if only!
por: Eckmann, Christian, et al.
Publicado: (2013)

Predictive value of procalcitonin and IL-6 for postoperative sepsis
por: Marx, G, et al.
Publicado: (2005)

Serum Procalcitonine Levels as an Early Diagnostic Indicator of Sepsis
por: Beqja-Lika, Anila, et al.
Publicado: (2013)

Serum procalcitonin as a diagnostic marker of neonatal sepsis
por: Park, In Ho, et al.
Publicado: (2014)

Procalcitonin as prognostic marker in severe sepsis of abdominal origin
por: Gonzalez-Lisorge, A, et al.
Publicado: (2015)

Combining procalcitonin with the qSOFA and sepsis mortality prediction
por: Yu, Hua, et al.
Publicado: (2019)

High serum procalcitonin concentrations in patients with sepsis and infection
por: Assicot, M., et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_e7h9vbvqfboueruk11chamglhi